Related references
Note: Only part of the references are listed.Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens
S. Moses Dennison et al.
JOURNAL OF VIROLOGY (2011)
Secreted Antiviral Entry Inhibitory (SAVE) Peptides for Gene Therapy of HIV Infection
Lisa Egerer et al.
MOLECULAR THERAPY (2011)
The IMGT/HLA database
James Robinson et al.
NUCLEIC ACIDS RESEARCH (2011)
Survival of the Fittest: Positive Selection of CD4+T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection
Janine Kimpel et al.
PLOS ONE (2010)
SC29EK, a Peptide Fusion Inhibitor with Enhanced α-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide
Takeshi Naito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46
Felix G. Hermann et al.
JOURNAL OF VIROLOGY (2009)
The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env
Vijay Sivaraman et al.
JOURNAL OF VIROLOGY (2009)
Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
Jacob Glanville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides
R. C. Zahn et al.
GENE THERAPY (2008)
Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor
Yuxian He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
In Silico tools for predicting peptides binding to HLA-class II molecules: More confusion than conclusion
Uthaman Gowthaman et al.
JOURNAL OF PROTEOME RESEARCH (2008)
On Evaluating MHC-II Binding Peptide Prediction Methods
Yasser El-Manzalawy et al.
PLOS ONE (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus
John J. Dwyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus
Jan van Lunzen et al.
MOLECULAR THERAPY (2007)
Development of HIV fusion inhibitors
SE Schneider et al.
JOURNAL OF PEPTIDE SCIENCE (2005)
Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides
S Lohrengel et al.
JOURNAL OF VIROLOGY (2005)
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV
E Gustchina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Rationally engineered therapeutic proteins with reduced immunogenicity
S Tangri et al.
JOURNAL OF IMMUNOLOGY (2005)
Resistance to enfuvirtide, the first HIV fusion inhibitor
ML Greenberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors
SA Gallo et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
M Egelhofer et al.
JOURNAL OF VIROLOGY (2004)
Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell Epitopes recognized in the context of HLA-A*0201
C Pelte et al.
JOURNAL OF IMMUNOLOGY (2004)
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide
S Walmsley et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Sequence variability analysis of human class I and class II MHC molecules: Functional and structural correlates of amino acid polymorphisms
PA Reche et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34
M Armand-Ugón et al.
ANTIVIRAL RESEARCH (2003)
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy
JP Lalezari et al.
AIDS (2003)
High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
C Demaison et al.
HUMAN GENE THERAPY (2002)
Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: Generation, concentration, and broad host range
WR Beyer et al.
JOURNAL OF VIROLOGY (2002)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Share Paper
